1. Drug-eluting and bare metal stents

Sirolimus-eluting coronary stent with ultra-thin struts (Supraflex)

TALENT
Objective
to compare the clinical outcome of the Supraflex stent with Xience stent (everolimus-eluting stent)
Study
prospective, randomised, single-blind, multicentre, non inferiority study (margin 4.0%)
Population
all-comers
Endpoints
composite of cardiac death, target-vessel MI or clinically indicated target-lesion revascularisation at 1 year
Conclusion
the Supraflex stent was non-inferior compared to Xience stent at 12 months in all-comer population
Zaman et al. Lancet 2019;393:987-97
Receive our newsletter


The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved